IXHL

MKT CAP:$39M

Incannex Healthcare Ltd ADR

Market Cap

$39M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$2.92-$8.78 (-75.04%)

Jun 5, 2026

52W High $48.9052W Low $2.56

Company Details

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixe...

CEO

—

IPO Date

Mar 2, 2022

Website

www.incannex.com

Key Metrics TTM (AUD)

Revenue

AUD 66.6K

-54.5% YoY

Net Income

-AUD 52M

EPS (Diluted)

Free Cash Flow

-AUD 22M

Revenue / Share

AUD 0.01

Gross Margin

-192.7%

Operating Margin

-45002.7%

Net Margin

-78634.3%

FCF Margin

-32822.4%

P/S

P/E

Earnings Reports

Q3 2026

May 15, 2026

AUD 0

Q2 2026

Feb 13, 2026

AUD 0-100.0%

Q1 2026

Nov 14, 2025

AUD 0-100.0%

FY 2025

Sep 29, 2025

AUD 86.0K+616.7%

Q4 2025

Sep 29, 2025

AUD 66.6K+270.8%

Revenue & Profitability (AUD)

Operating Cash Flow (AUD)

CapEx Spend (AUD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (AUD)

OpEx Breakdown (AUD)

War Chest (AUD)

Shares Outstanding

Revenue Per Employee (AUD)

Revenue / Employee